Neoadjuvant systemic therapy was acceptable to 70% of patients, with 69% of those willing to undergo renal mass biopsy first. While 52% would consider neoadjuvant systemic therapy for ≥16 weeks and 56 ...

ABINGTON, Pa. (WPVI) -- To treat or not to treat? It's a common dilemma when cysts and masses are found by accident during tests for other medical conditions. A new study from Fox Chase Cancer Center ...

With another successful pig kidney transplant, Mass General has been approved to proceed with a larger FDA-approved clinical ...

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free ...

FDA clears Cambridge biotech eGenesis and Mass General to expand pig kidney transplants in first U.S. trial, perhaps a step toward easing organ shortages.

Doctors at Mass General Brigham performed their second successful pig kidney transplant.This was the third overall surgery to implant the organ successfully.<a class="excerpt-read-more" href=" More ...

Scientists continue to make progress with research on how well pig organs might perform in humans, and now they’re ready for the next step: larger-scale clinical trials.

Stewart’s case marks another step forward for the Mass General team, which is also following the progress of Tim Andrews, a ...

FDA-approved clinical trial will allow Mass General Hospital and eGenesis to involve transplant patients nationwide.